from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1789/PPE26

LFCtreatmentdescriptionclass of inhibitor

1.031

Amikacinug/mL Amikacintranslation

1.362

Cap5-10ug/mL Capreomycintranslation

1.829

Rox10-50 ug/mL Roxithromycintranslation

0.445

SM2-5 ug/mL Streptomycintranslation

1.632

Tet5-10 ug/mL Tetracyclinetranslation

-1.179

Rif0.2-5ug/mL Rifampicintranscription

-0.829

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.261

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.394

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.193

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.168

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.159

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.317

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.220

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.166

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.408

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.026

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.203

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.185

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.278

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.429

KCN5-20 ug/mL Potassium cyaniderespiration

-0.314

NaN30.2-2 mM Sodium aziderespiration

0.558

Nigericin50 uM Nigericinrespiration

-0.920

TRC10-150 ug/mL Triclosanrespiration

0.261

TRZ10-25 ug/mL Thioridazinerespiration

-0.338

Valinomycin0.5-10 uM Valinomycinrespiration

-0.301

ZnSO42 mM ZnSO4respiration

-0.163

menadione6-10 ug/mL Menadionerespiration

0.662

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.318

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.280

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.095

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.059

NRP_1Non-replicating persistence stage 1dosRassociated

0.476

Amp0.2mg/mL AmpicillincellWall

0.239

Cephalexin20-100 ug/mL CephalexincellWall

0.739

Cerulenin0.32-5 ug/mL CerulenincellWall

0.449

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.835

EMB10-20 ug/mL EthambutolcellWall

0.510

Eta12-40 ug/mL EthionamidecellWall

1.209

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.388

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.208

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.379

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.425

BZA0.12 mg/mL BenzamidearomaticAmides

-0.983

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.011

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.591

H2O24 mM hydrogen peroxideDNAdamaging

0.656

Levo10 ug/mL LevofloxacinDNAdamaging

-0.530

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.390

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.656

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.646

UVUV-irradiationDNAdamaging

-0.085

ARP41-4 ug/mL Antitubercular compound ARP4?

0.013

Antimycin12.5-50 ug/mL Antimycin A?

0.322

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.436

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.414

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.526

PA8240.2-2 ug/mL PA-824?

0.370

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.749

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.490

Verapamil50 uM Verapamil?

0.257

mercaptoethanol2 mM 2-Mercaptoethanol?

0.145

methoxatin10-20 ug/mL Methoxatin?